Teva Pharmaceutical Industries Share Holder Equity 2010-2024 | TEVA

Teva Pharmaceutical Industries share holder equity for the quarter ending September 30, 2024 was $6.383B, a 15.03% decline year-over-year.

  • Teva Pharmaceutical Industries share holder equity for 2023 was $8.126B, a 5.49% decline from 2022.
  • Teva Pharmaceutical Industries share holder equity for 2022 was $8.598B, a 23.53% decline from 2021.
  • Teva Pharmaceutical Industries share holder equity for 2021 was $11.244B, a 1.65% increase from 2020.

Teva Pharmaceutical Industries Share Holder Equity 2010-2024 | TEVA

  • Teva Pharmaceutical Industries share holder equity for 2023 was $8.126B, a 5.49% decline from 2022.
  • Teva Pharmaceutical Industries share holder equity for 2022 was $8.598B, a 23.53% decline from 2021.
  • Teva Pharmaceutical Industries share holder equity for 2021 was $11.244B, a 1.65% increase from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M